I agree that this site is using cookies. You can find further informations here.
X
Barlési, Fabrice
664  results:
Search for persons X
?
1

Final results of urelumab, an anti-CD137 agonist monoclonal..:

Khushalani, Nikhil I ; Ott, Patrick A ; Ferris, Robert L...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e007364 , 2024
Link: https://doi.org/10.1136/..
 
?
2

PP01.08 Real-world outcomes of first-line anti-PD(L)1-based..:

Barlesi, Fabrice ; Dasgupta, Anandaroop ; Latremouille-Viau, Dominick...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e11-e12 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Impact of pembrolizumab treatment duration on overall survi..:

Rousseau, Adrien ; Michiels, Stefan ; Simon-Tillaux, Noémie...
The Lancet Regional Health - Europe.  43 (2024)  - p. 100970 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Reactions and adverse events induced by T-cell engagers as ..:

Géraud, Arthur ; Hueso, Thomas ; Laparra, Ariane...
European Journal of Cancer.  205 (2024)  - p. 114075 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Capmatinib plus nazartinib in patients with EGFR-mutated no..:

Felip, Enriqueta ; Metro, Giulio ; Soo, Ross A....
European Journal of Cancer.  208 (2024)  - p. 114182 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Meta-Analysis on the Combination of Chemotherapy With Progr..:

Tagliamento, Marco ; Di Maio, Massimo ; Remon, Jordi...
Journal of Thoracic Oncology.  19 (2024)  1 - p. 166-172 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Avelumab Versus Platinum-Based Doublet Chemotherapy as Firs..:

Reck, Martin ; Barlesi, Fabrice ; Yang, James Chih-Hsin...
Journal of Thoracic Oncology.  19 (2024)  2 - p. 297-313 , 2024
Link: https://doi.org/10.1016/..
 
?
8

PP01.09 Real-world clinical outcomes after progression with..:

Liu, Stephen V. ; Dasgupta, Anandaroop ; Latremouille-Viau, Dominick...
Journal of Thoracic Oncology.  19 (2024)  7 - p. e12 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Toxicity of immunotherapy combinations with chemotherapy ac..:

Rached, Layal ; Laparra, Ariane ; Sakkal, Madona...
Cancer Treatment Reviews.  127 (2024)  - p. 102751 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Long-Term Outcomes After Concurrent Once- or Twice-Daily Ch..:

Walls, Gerard M. ; Mistry, Hitesh ; Barlesi, Fabrice...
International Journal of Radiation Oncology*Biology*Physics.  , 2024
Link: https://doi.org/10.1016/..
 
?
11

PACIFIC-9: Phase III trial of durvalumab + oleclumab or mon..:

Barlesi, Fabrice ; Cho, Byoung Chul ; Goldberg, Sarah B...
Future Oncology.  , 2024
Link: https://doi.org/10.1080/..
 
?
12

Correction: Metabolomic analyses of COVID-19 patients unrav..:

Danlos, François-Xavier ; Grajeda-Iglesias, Claudia ; Durand, Sylvère...
Cell Death & Disease.  15 (2024)  2 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
13

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versu..:

Vokes, Everett E. ; Mornex, Francoise ; Sezer, Ahmet...
Journal of Thoracic Oncology.  19 (2024)  2 - p. 285-296 , 2024
Link: https://doi.org/10.1016/..
 
?
14

STK11/LKB1 alterations worsen the poor prognosis of KRAS mu..:

Baptiste Oudart, Jean ; Garinet, Simon ; Leger, Caroline...
Lung Cancer.  190 (2024)  - p. 107508 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Bintrafusp Alfa Versus Pembrolizumab in Patients With Treat..:

Cho, Byoung Chul ; Lee, Jong Seok ; Wu, Yi-Long...
Journal of Thoracic Oncology.  18 (2023)  12 - p. 1731-1742 , 2023
Link: https://doi.org/10.1016/..
 
1-15